Subscribe to our weekly International update on Health Policies

Raffaella Ravinetto

ITM
 

Featured Articles

The often lethal “side effects” of sanctions on pharmaceutical systems

Sanctions are political and economic measures that are part of the political and diplomatic response against states or organizations that threaten international law. They are meant to restore international law, promote peace and security, discourage human rights violations, and put an end to extremist behavior. Sanctions can be imposed by state...

The global gap in access to opioid analgesics for pain management: why is this (still) a silent crisis?

Opioid analgesics are essential medicines, needed for treating acute and chronic pain. Morphine, methadone, hydromorphone, oxycodone, codeine and fentanyl are all listed in the WHO Model Lists of Essential Medicines. However, being “attractive” for illicit use and abuse, they are also listed as “controlled substances” under the Single C...

Towards a new structural approach to pharmaceutical innovation, intellectual property and public health: If not now, when?

In 1994, the General Agreement on Tariffs and Trade  (GATT), a provisional organization that had been providing the rules for world trade since 1948, was replaced by the World Trade Organization (WTO). The Marrakesh Agreement  formally established the WTO. Under normal circumstances, only specialists would be familiar with this document. Howeve...

Switching the poles of infectious diseases outbreaks: Time for a new gaze?

Early May, a review paper on Ebola published in the New England Journal of Medicine triggered some controversy, being authored by researchers from high-income countries only. Among  other things, the review reminded us that safe burial practices that respect cultural values are needed to prevent Ebola transmission during traditional funerals. T...

Gaps in Access to Medicine : Unavoidable injustice or economic paradigm shift required?

Attending the 4th Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference in Vienna last month (23-24 October), allowed the first author of this blog to revisit issues surrounding the unequal access to medicines, from the perspective of a health economist. Further discussion with the second author, a pharmacist highly concerned by...

Blogs